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Supplementary Table S2: KRAS and BRAF variations identified in this study by next-generation sequencing
Supplementary Figure S5 -S13: Variation profile of 48 genes based on clinicopathological features. Hierarchical cluster analysis result for all patients (S5), and stratified cluster analysis indicated that no obvious differences of variation profile were found between sex (S6), age (S7), tumor sites (S8), tumor sizes (S9), mitosis (S10), CD117 (S11), DOG-1 (S12), and CD34 (S13) expressions.
